Abstract In order to identify new markers of vascular cell senescence with potential in vivo implications, primary cultured endothelial cells, including human umbilical vein endothelial cells (HUVECs), human aortic endothelial cells (HAECs), human coronary artery endothelial cells (HCAECs) and ex vivo circulating angiogenic cells (CACs), were analysed for microRNA (miR) expression. Among the 367 profiled miRs in HUVECs, miR-146a, miR-9, miR-204 and miR-367 showed the highest up-regulation in senescent cells. Their predicted target genes belong to nine common pathways, including Toll-like receptor signalling (TLR) that plays a pivotal
Introduction
Multiple factors, including vascular cell senescence, may contribute to impaired endothelial functions in elderly people (Kovacic et al. 2011) . The endothelial senescence status induced by ageing appears to be accelerated in the presence of pro-inflammatory agerelated pathological conditions, including coronary artery disease and chronic heart failure (CHF) (Minamino et al. 2002; Minamino and Komuro 2007) . Although specific pathways of vascular cell senescence have been identified, a complete understanding of this intricate process is still limited (Passos et al. 2009 ). Senescent endothelial cells are characterised by telomere shortening which occurs as a consequence of cellular replication and can be accelerated by harmful environmental factors, such as oxidative stress (Voghel et al. 2007) . When telomeres reach a critical threshold, endothelial cells become dysfunctional with an increased proinflammatory factors expression, resulting in a profile defined as 'senescence-associated secretory phenotype' (SASP) (Donato et al. 2008; Sikora et al. 2011; Saliques et al. 2010) . Secreted pro-inflammatory proteins acting in both autocrine and paracrine ways contribute to the senescent phenotype (Passos et al. 2009 ). The acquisition of SASP reduces endothelial regenerative properties which in turn contribute to the development of proinflammatory pathological conditions (Freund et al. 2010; Testa et al. 2011; Olivieri et al. 2009 Olivieri et al. , 2012 . Although the evidence of endothelial cell senescence in the vasculature is gaining increasing recognition, the clinical relevance of this process is currently hampered by the unavailability of non-invasive techniques and biomarkers assessing endothelial cell senescence in vivo. Thus, the identification of new cellular and/or circulating markers of vascular senescence may hold important clinical relevance.
MicroRNAs (miRs) are regulatory elements influencing gene expression throughout the lifetime (Liang et al. 2009; Martinez et al. 2011) . Several independent lines of evidence have indicated a critical role for miRs, as biomarkers of cellular senescence, in both replicative and stress-induced modulation of in vitro cellular senescence (Lafferty-Whyte et al. 2009; Poliseno et al. 2008; Wagner et al. 2008; Li et al. 2009 Li et al. , 2010 Olivieri et al. 2009 ). Human umbilical vein endothelial cells (HUVECs) have been extensively used as an in vitro endothelial model representing common functional and morphological features of the in vivo endothelial cells (Unterluggauer et al. 2007) . This model was recently used to identify miRs and their relative target proteins associated with replicative and/or stress-induced senescence (Ito et al. 2010; Menghini et al. 2009; Hackl et al. 2010; Vasa-Nicotera et al. 2011; Magenta et al. 2011 ). However, these recent reports have not been conclusive on identifying specific miRs as markers of vascular ageing-associated dysfunction in vivo.
The present research focused on the identification of miRs associated with senescence status in vascular remodelling cells. For this purpose, we identified specific miRs strongly associated with the senescent phenotype in different in vitro cultured endothelial cells, such as HUVECs, human aortic endothelial cells (HAECs) and human coronary artery endothelial cells (HCAECs).
Furthermore, since in vivo data on the role of senescence-associated miRs in vascular remodelling are still scarce, a vascular progenitor cell subpopulation of circulating angiogenic cells (CACs) was analysed. Even if CACs derive from the monocytemacrophage lineage and are characterised by a reduced capacity to form blood vessels in vivo, they contribute to vascular homeostasis by secreting angiogenic growth factors in vascular injury sites (Rehman et al. 2003) . Thus, CACs are 'cells involved in vascular remodelling' easily obtainable from peripheral blood. Since we previously demonstrated that CACs from CHF patients showed the distinguishing feature of senescence, such as telomere attrition, reduced telomerase activity and increased pro-inflammatory status, compared to CACs from healthy control subjects (CTR), we used the same study population to validate the expression levels of miRs associated with senescent phenotype of cultured endothelial cells (Olivieri et al. 2012) .
Experimental procedures

Cell culture
HUVECs, HAECs and HCAECs were purchased from Clonetics Corporation (Lonza, Basel, Switzerland) and cultured in endothelial growth medium EGM-2 (Lonza) (see Supplementary material and method). Endothelial cell replicative senescence was studied by subjecting endothelial cells to subsequent passages until XIII, as previously described (Haendeler et al. 2004 ). Cumulative population doubling (CPD) was calculated as the sum of all the changes in PD (Supplementary material and method). SA-β-gal activity was assessed as reported in Supplementary material and method.
Cytokines production
The cell supernatants were collected at the end of each passage before tripsinisation, centrifuged and stored at −20°C until the assays. Interleukin (IL)-1β, IL-1α, IL-2, IL-6, IL-8, IL-10, IL-12, tumour necrosis factor (TNF)-a, interferon (INF)-γ and myeloperoxidase (MPO) concentration were measured by means of commercially available high-sensitivity enzymelinked immunosorbent assay kits (Search Light, Thermo Scientific, Rockford, IL, USA).
Telomere length determination
Telomere length analysis was performed by using both the traditional absolute quantification method (TRF) and relative telomere length analysis (assessed as T/S ratio, telomeric template (T) vs. a single gene copy (S)) based on quantitative polymerase chain reaction (PCR) Cawthon's method (Cawthon 2002) . Detailed methods were reported in Supplementary material and method.
Telomerase (TERT) activity assay Quantitative determination of telomerase activity was performed using a validated quantitative telomerase detection kit (Allied Biotech, Inc., Ijamsville, MD, USA) (high-sensitive real-time quantitative Telomeric Repeat Amplification Protocol) according to the manufacturer's protocol (Wege et al. 2003 
RNA isolation
Total RNA from cells (HUVECs, HCAECs, HAECs and CACs) was isolated using RNA purification kit (Norgen Biotek Corporation, Thorold, ON, Canada) which allows isolation of both enriched miRs and larger RNA species. The RNA was stored at −80°C until use.
Microarray analysis of mature microRNAs
About 150-200 ng of total RNA was converted to cDNA by priming with a mixture of looped primers using the manufacturer's instructions (MegaPlex kit, Applied Biosystems, Foster City, CA, USA). Preamplification was performed using 3 μl of input RNA with PreAmp kit (Applied Biosystems). Nine microlitres of pre-amplified cDNA was used for mature miRs profiling by real-time PCR instrument equipped with a 348-well reaction plate (7900 HT, Applied Biosystems) and human miR Array pool A (Applied Biosystems) containing 367 different human miR assays in addition to selected small nucleolar RNAs.
Quantitative RT-PCR of mature microRNAs MiRs were quantified using TaqMan MicroRNA Assay (Applied Biosystems) with some modifications. Briefly, total RNA was reverse-transcribed with the TaqMan MicroRNA reverse transcription kit. Five microlitres of RT reactions contained 1 μl of each miR-specific stem-loop primers, 1.67 μl of input RNA, 0.4 μl of 10 mM dNTPs, 0.3 μl of reverse transcriptase, 0.5 μl of 10× buffer, 0.6 μl of RNAse inhibitor diluted 1:10 and 0.5 μl of H 2 O 2 . The mixture was incubated at 16°C for 30 min, 42°C for 30 min and 85°C for 5 min. Subsequently, quantitative realtime PCR was performed in 20 μl of PCR reaction containing 1 μl of 20× Taqman miR Assay in which PCR primers and probes (5′-FAM) were contained, 10 μl of 2× TaqMan Universal Master mix no UNG (Applied Biosystems) and 5 μl of RT product. The reaction was first incubated at 95°C for 2 min followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. Data were analysed with real-time PCR OpticonMonitor version 2 (MJ Research, Bio-Rad, Hercules, CA, USA), with the automatic Ct setting for adapting baseline. Detection thresholds were set to 35 Ct. The relative amount of each miRNA was calculated using the comparative threshold (Ct) method with ΔCt 0 Ct(miRNA) − Ct(RNU44). We used different normalisation methods for arrays and realtime quantitative PCR (RT-qPCR). Relative quantification of miRNA expression was calculated with the 2 −ΔΔCt method. In this way, all the reported miR expression values obtained with RT-qPCR are normalised using either RNU44 and RNU48 expression. Moreover, miR-199b-5p, a stable miR expressed in young and senescent HUVECs, was also used. Independent samples t test was used to determine statistical significance between samples. P values less than 0.05 were considered significant.
Computational prediction of microRNA target genes
In order to increase the efficiency of identifying common mRNA targets to more than one miR and identify new miRs in the senescence pathway, a previously developed computer programme, named SID1.0 (simple String IDentifier), was used (Albertini et al. 2011 ). This programme is based on the strategy of exhaustive search and specifically designed to screen shared data (target genes, miRs and pathways) available from PicTar and DIANA-MicroT 3.0 databases. For a defined miR name, target genes can be automatically retrieved from the DIANA-MicroT 3.0. The list IDs are indexed using SID1.0 that looks for KEGGs pathway database IDs shared by the predicted miRs of the different datasets. In this way, we were able to obtain the common pathways of specific miRs.
As described by Papadopoulos et al. (2009) , the input of DIANA-mirPath is a list of miRs target genes defined in a user-friendly web interface by simply selecting the miR name and, in our case, the target prediction software TargetScan (Lewis et al. 2005 ). In the DIANA-mirPath output page, all pathways are sorted according to a descending enrichment statistical score (−lnP) along with the number and names of each miR's target genes involved in each KEGG pathway. The input dataset enrichment in each KEGG pathway is represented by the negative natural logarithm of the P value (−lnP).
Protein extraction and immunoblotting
Cells were washed twice in cold PBS. Total protein was extracted using RIPA buffer (150 mM NaCl, 10 mM Tris, pH 7.2, 0.1 % SDS, 1.0 % Triton X-100, 5 mM EDTA, pH 8.0) containing protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN, USA). Protein concentration was determined using Bradford reagent (Sigma-Aldrich, Milan, Italy). Total protein extracts (40 μg) were separated by 10 % SDS-PAGE and transferred to PVDF membrane (Bio-Rad). Membranes were incubated overnight with primary antibodies anti-IRAK1 (MBL, International Corporation Inc. Woburn, MA, USA) or anti-TRAF6 (Santa Cruz Biotechnology, Sta. Cruz, CA, USA). Then, they were incubated with a secondary antibody conjugated to horseradish peroxidase for 1 h at room temperature. Immunoreactive proteins were visualised using chemiluminescence substrate (ECL Plus, GE Healthcare, Pittsburgh, PA, USA). As endogenous control, the membrane was incubated with anti-β-actin (Santa Cruz Biotechnology).
Cell transfection
Transient transfection of miRs was performed with FuGENE transfection reagent (Roche Applied Science), according to the manufacturer's instructions. In brief, 8×10 4 cells were plated in six-well plates and kept overnight for attachment. The next day, cells were transfected with miR-146a mimic (146aM), inhibitor (anti-miR-146a) or negative miR control mimic (ConM) (Dharmacon, Inc. Chicago, IL, USA). The FuGENE transfection method was optimised testing different quantities of reagent and miR. In particular, FuGENE (microlitre)/miR (microgram) ratios of 3:1 were found as optimal. It is important to underline that the transfection FuGENE-miR complex was prepared in serum-free medium. Analyses were performed 72 h after transfection.
MiR-146a expression in CACs and plasma obtained from CHF and CTR CAC isolation and characterisation have been recently reported in Olivieri et al. (2012) . Briefly, CACs were isolated from approximately 14 ml of heparinised peripheral blood after density-gradient centrifugation. PBMCs (5×10 6 ) were plated on 24-well fibronectin-coated plate and maintained in endothelial basal medium supplemented with EGM SingleQuots and 20 % FCS for 4 days. After 4 days in culture, non-adherent cells were removed by PBS wash, while adherent cells were lysed directly in the culture wells. To confirm the CAC phenotype, each sample was tested for the ability to incorporate 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine-labelled acetylated LDL (DiLDL) and bind endothelial-specific lectins, such as Ulex europaeus agglutinin-1. More than 95 % of adherent cells were bound to UEA-1 and endocytosed DiLDL and consequently regarded as CACs.
Total RNA was extracted from CACs and 100 μl of plasma. MiRs were quantified by RT-qPCR using TaqMan miRNA assays (Applied Biosystems), according to the manufacturer's protocol. All RT-qPCR data were analysed as unadjusted Ct values and standardised to miR-17, a miR which was previously validated (D'Alessandra et al. 2010) and fulfilled the following criteria: detectable in all samples, low dispersion of expression levels and null association with CHF. The Ct values from RT-qPCR assays greater than 35 were treated as not expressed. MiR relative expression distribution values were calculated as 2 −ΔCt , (ΔCt 0 Ct miR-X − Ct miR-17). MiR relative fold changes were calculated using the 2 −ΔΔCt method setting 1 as an arbitrary value for the control group.
Statistical analysis
Statistical analysis of microarray data: miRs expressed at detectable level in more than 80 % of samples were compared based on their relative expression to the overall miR expression on each array, using median normalisation analysis. The ΔΔCT for each miR was defined as the difference of expression between senescent and young cells. 
Results
Characterisation of replicative senescence and cytokine release in HUVEC cells
HUVECs were maintained in culture until growth arrest (XIII passage). Population doubling, senescenceassociated β-galactosidase (SA-β-gal) staining, telomere length and telomerase activity indicated a progressive acquisition of senescence status ( Supplementary Fig. 1a-d Fig. 2 and Table 1 ).
MicroRNA profile in replicative senescence HUVEC cells
To identify different miR expressions in young and replicative senescent HUVEC cells, 367 human miRs were profiled in cells at the II (young) and XIII (senescent) passages. Up to 265 miRs were expressed at a detectable level in almost all of the samples tested (more than 80 %) and were included in the final analysis. Thirty-four miRs were differentially expressed in senescent compared to young cells. Among them, 23 miRs were up-regulated, while 11 miRs were down-regulated (Fig. 1) . Complete profiling results are reported in Supplementary Table 2 . Moreover, profiling data have been deposited in NCBI's Gene Expression Omnibus (Edgar et al. 2002) and are accessible through GEO Series accession number GSE37972 (http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc0GSE37972).
Identification of the common pathways and target genes of up-regulated microRNAs in senescent HUVEC cells
The number of up-regulated miRs in senescent HUVECs was greater than the number of downregulated ones (Fig. 1) . We focused on the former, in order to identify protein targets involved in downregulated common pathways during the senescence process. MiR-146a, miR-204, miR-367 and miR-9 were the highest up-regulated miRs in senescent compared to young HUVECs, with an increase of more than 3.5-fold. SID1.0 analysis identified nine pathways common to miR-146a, miR-204, miR-367 and miR-9 (Table 1 ) with a −ln(P value) higher than 1.5, including Toll-like receptor (TLR) signalling pathway. In Fig. 2 , miR-146a, miR-204, miR-367 and miR-9 predicted target genes belonging to the TLR pathway are shown.
Among deregulated miRs in senescent HUVECs, miRNA-146a was the highest up-regulated miR, showing a −ln(P value) of 4.9 for its predicted target genes: IL-1 receptor-associated kinase (IRAK1), TNF receptor-associated factor 6 (TRAF6) and CD80, all involved in TLR signalling (Table 2) . Interestingly, miR-146a is a validated modulator of IRAK1 and TRAF6 (Nahid et al. 2011) , which are key proteins involved in cytokine production (Table 2) . Thus, we validated IRAK1 and TRAF6 as protein targets of miR-146a in endothelial cells.
Validation of microRNA-146a up-regulation in replicative senescent endothelial cells
The hyper-expressed miR-146a, miR-204, miR-367, miR-9 and the hypo-expressed miR-148 were validated with RT-qPCR in senescent cells (data not shown). Moreover, miR-146a expression was also validated by RT-qPCR in HAECs and HCAECs, confirming the up-regulation of this miR in senescent cells compared to the younger ones (Fig. 3) . MiR-146a was about 10-fold, 30-fold and 4-fold increased in senescent HUVECs, HCAECs and HAECs, respectively (Fig. 3) .
All reported miR expression values obtained with RT-qPCR were normalised using the RNU44 expression. Moreover, to reduce a possible bias of the normalisers implied, RNU48 transcript was also used as an alternative normaliser, confirming results obtained with RNU44 (data not shown). In addition, miR-199-5p, one of the most stably expressed miR in young and senescent HUVECs (as shown by profiling data; Supplementary Table 2 ) was also used for normalisation, confirming an increased miR-146a expression in senescent HUVECs (data not shown). Moreover, significant correlations were observed between miR-146a expression levels and CPD (Pearson correlation, 0.86, P<0.01), SA-β-gal activity (Pearson correlation, 0.85, P<0.01), TRF (Pearson correlation, −0.78, P<0.01) and TERT activity (Pearson correlation, −0.54, P<0.05) during HUVECs in vitro senescence.
MicroRNA-146a expression in H 2 O 2 -stressed HUVEC cells
To address the involvement of miR-146a either on senescence phenotype or oxidative stress status, we investigated miR-146a expression after H 2 O 2 treatment of young and senescent HUVEC cells. The treatment induced an expression peak for miR200c and co-transcribed miR-141 (Fig. 4) , but no significant change in miR-146a expression was found (Fig. 4) . These results confirmed those recently reported by Magenta et al. (2011) . . Data are reported as the mean value (three young vs. three senescent samples) of three independent experiments. A 2-fold or greater difference was considered significant, and only miRs with a ΔΔCT higher than 2 or lower than −2 were reported in the figure MicroRNA-146a protein targets expression in HUVECs IRAK1 expression was highly reduced in senescent (XIII passage) compared with young (II passage) HUVECs, while TRAF6 was not significantly modulated (Fig. 5a) . Similarly, the over-expression of miR146a in HUVEC senescent cells correlated with the down-regulation of its protein target IRAK1 but not with TRAF6. In order to directly correlate miR-146a expression with IRAK1 and TRAF6 protein expression levels, SA-β-gal activity and IL-6 release, young and senescent HUVEC endothelial cells were transfected with miR-146a mimic and antagomir. Young and senescent transfected cells showed miR-146a increased expression of approximately 27-and 25-fold vs. non-transfected cells, respectively. Transfectioninduced over-expression of mature miR-146a significantly inhibited IRAK1 protein. As expected, knockdown of endogenous miR-146a with an oligonucleotide antimir (anti-miR-146a) significantly increased IRAK1 protein expression both in young and senescent HUVEC cells, while any effect on TRAF6 protein expression was observed (Fig. 5b) . IL-6 release and SA-β-gal activity were not different in young and senescent HUVECs transfected with miR-146a mimic (146aM) and antagomir (antimiR-146a) (data not shown). Together, these data establish that the transient modulation of miR-146a has an independent effect on IRAK1 regulation without affecting TRAF6 expression, IL-6 release and SA-β-gal activity in HUVEC cells. Small cell lung cancer hsa05222
Glycan structures-biosynthesis 1 hsa01030
Axon guidance hsa04360
Neuroactive ligand-receptor interaction hsa04080
Cell adhesion molecules (CAMs) hsa04514
Erb signalling hsa04012
Ubiquitin-mediated proteolysis hsa04120
Toll-like receptor signalling hsa04620
Pathway name and the identification ID used by KEGG database were reported. The database used for this analysis was DIANA-MicroT 3.0 MicroRNA-146a expression in CAC and plasma of CHF patients and healthy CTR
We recently reported that senescence-associated biomarkers, such as telomere attrition and telomerasereduced activity, were increased in CACs from CHF patients compared to healthy CTR (Olivieri et al. 2012) . Therefore, we checked whether miR-146a could be also modulated in cells and plasma from CHF patients vs. CTR. In particular, miR-146a expression was measured in CACs, leukocytes and plasma obtained from a subset of 35 CHF patients and 37 healthy CTR from a previous study (Olivieri et al. 2012 ) and reported in Table 3 . MiR-146a expression increased approximately 1,000-fold in CACs (Fig. 6a ) and 2-fold in plasma of CHF patients compared to CTR (Fig. 6b ), but did not reach statistical significance in CHF compared to CTR leukocytes (data not shown). According to senescent HUVEC cells, IRAK1 expression was highly reduced in CACs of CHF patients compared to those of healthy subjects (Fig. 7) . Furthermore, significant correlations were observed between miR-146a expression levels and telomere length, as T/S (Pearson correlation, −0.19, P<0.05) and TERT activity (Pearson correlation, −0.16, P<0.05) in CACs from CHF patients and CTR subjects.
Discussion
Human endothelial cells undergo senescence both in vivo and in vitro, providing a useful model for the identification of new specific and sensitive markers of vascular cell senescence. Using a microarray approach, we found that the expression of several miRs is modulated in HUVEC senescent cells. Interestingly, there was an almost 2-fold increase in up-regulated miRs compared to down-regulated ones in senescent cells. This finding is in accordance with data reported regarding in vitro cultured cells and tissues of aged animals and humans, suggesting that an over-expression of miRs might counteract the age-related increase in the expression of protein-encoding genes (Maes et al. 2009; Bates et al. 2010; Li et al. 2009 ). Among the 367 profiled miRs, miR-146a, miR-9, miR-204 and miR-367 were significantly up-regulated in senescent vs. young cells with miR-146a showing the highest expression. Our data correlated with those of previous reports on trabecular meshwork cells and human foreskin fibroblasts (BJ) Bonifacio and Jarstfer 2010; Christoffersen et al. 2010; Bhaumik et al. 2009 ). However, previous data on miR-146a expression in HUVECs during replicative senescence showed conflicting results (Hackl et al. 2010; Vasa-Nicotera et al. 2011 ). In particular, Hackl et al. (2010) reported no significant change of miR-146a expression in senescent HUVECs, whereas Vasa-Nicotera et al. (2011) observed a significant decrease of miR-146a expression in senescent cells. Interestingly, we found an up-regulation of miR-146a expression not only in HUVECs, but also in HAEC and in HCAEC senescent cells, confirming that its up-regulation is associated with senescent phenotype in different vascular cell types. We cannot exclude that contrasting results on miR-146a expression in senescent HUVEC cells could depend on the different strains used in previous investigations. In fact, a HUVEC strain-specific expression of inflammatory cytokines during in vitro senescence was previously reported, suggesting that young HUVECs of different strains could be characterised by different pro-inflammatory status, blunting the acquisition of a pro-inflammatory phenotype during replicative senescence (Garfinkel et al. 1994) . Another possibility for discrepancies could be due to the choice of different normalisers. At present, there is no consensus on normalisation for either hybridisation microarray or RTqPCR and the choice of a normalisation method could be a bias (Meyer et al. 2010) . For these reasons, we used different normalisation methods for arrays and RTqPCR. In particular, RNU44 and RNU48 were used for their abundance and low variability across different normal tissues and cell lines (Wong et al. 2007 ). Names and −ln(P value) of miR-146a predicted target genes found in each pathway were reported
Moreover, miR-199b-5p, which is stably expressed in young and senescent HUVECs (as confirmed by our profiling results), was also used. In all cases, the upregulation of miR-146a in senescent cells was confirmed.
In order to render a fast and efficient approach for the identification of common pathways of the most upregulated miRs, such as miR-146a, miR-204, miR-367 and miR-9, in senescent cells, we used the SID1.0 computer programme, which has been recently MiR-146a expression at first passage was arbitrarily set to 1. Data are reported as means + SD obtained from three independent experiments in duplicates developed by our group (Albertini et al. 2011) . SID1.0 analysis identified nine common pathways, including the pro-inflammatory TLR signalling pathway. As inflammation is a key feature of ageing, we focused on the TLR pathway including miR-146a target genes with an high prediction score (−ln(P value) higher than 1.5). In particular, we investigated two proteins involved in this pathway: TRAF6 and IRAK1. MiR146a was previously reported to regulate an inflammatory response by repressing TRAF6 and IRAK1 expression in fibroblast and meshwork cells (Freund et al. 2010; Li et al. 2010) . Both proteins are involved in the transcription of pro-inflammatory molecules, including IL-6, acting in an autocrine feedback loop to reinforce the senescence growth arrest and the acquisition of SASP (Freund et al. 2010; Ma et al. 2011) .
Our results show that miR-146a hyper-expression mediates IRAK1 repression in human senescent endothelial cells (HUVECs): miR-146a transfection in HUVECs induced a down-regulation of IRAK1 protein, whereas knockdown of endogenous miR-146a increased its level, extending previous findings on fibroblasts (Taganov et al. 2006; Campisi and d'Adda di Fagagna 2007; Li et al. 2010 ) even if miR-146a modulation of TRAF6 was not confirmed in our endothelial cell model. Furthermore, we observed an increased cytokine release in senescent compared to younger HUVECs, suggesting that IRAK1 down-regulation is not sufficient to counteract the acquisition of SASP in endothelial cells. Indeed, when senescent HUVECs were transiently transfected with miR-146a mimic, IL-6 production was not consistently modified. These data suggest that the acquisition of SASP during replicative senescence is not fully controlled by miR-146a. Further studies are in progress to clarify the role of the other three upregulated miRs in senescent cells, involved both in the TLR pathway and inflammatory response (Bazzoni et al. 2009; Li et al. 2011) .
We also observed an increased release of MPO in HUVEC senescent cells, indicative of an increased oxidative stress. However, our findings clearly show that miR-146a is not involved in oxidative stress response in neither younger nor senescent HUVECs. These results are in accordance with previous data showing that robust expression of miR-146a is not associated with growth arrest or stress-induced stasis (Bhaumik et al. 2009; Magenta et al. 2011; Li et al. 2009 ). We also confirmed that miR-200c and miR-141 were up-regulated in younger and senescent HUVECs in response to oxidative stress (Magenta et al. 2011; Li et al. 2009 ). Interestingly, miR-146a expression was validated in CACs obtained from CHF patients and CTR subjects. This ex vivo cellular model was chosen because CACs are involved in vascular renewal and can be easily purified from peripheral blood, and CACs obtained from CHF patients have a distinguishing feature of senescence (Olivieri et al. 2012; Fadini et al. 2008; Rehman et al. 2003) . A 1,000-fold increase of miR-146a expression along with a strong reduction of IRAK1 expression was observed in CACs of CHF patients compared to CTR. Interestingly, significant anti-correlations between miR146a expression and telomere length and telomerase CTR healthy control subjects, CHF congestive heart failure, CACs circulating angiogenic cells, hs-CRP high sensitivity C-reactive protein, LVEF left ventricular ejection fraction, NT proBNP N-terminal prohormone brain natriuretic peptide, T2DM type 2 diabetes mellitus, IQR interquartile range, SD standard deviation Fig. 6 MiR-146a expression in CACs and plasma from CHF patients (n037) and CTR subjects (n035). CACs circulating angiogenic cells, CTR healthy control subjects, CHF congestive heart failure. *P from general linear model, age and sex adjusted, P<0.05. Box: interquartile range; horizontal line in the box: median value; whiskers: minimum and maximum values activity were observed. These data reinforce the hypothesis that cellular senescence associated with a proinflammatory status could play a role in vascular dysfunction involved in age-related diseases, such as CHF. Interestingly, the increased expression of miR-146a did not reach significant levels in leukocytes obtained from the same setting of patients, which may be explained by the heterogeneity of leukocyte subpopulations (Lin et al. 2010) . We also observed a 2-fold over-expression of plasma levels of miR-146a in CHF patients. It was hypothesised that an up-regulation of miR146a in senescent cells may serve to prevent an excessive production of inflammatory mediators, thus limiting some of the potentially deleterious effects of the SASP . Interestingly, it was recently reported that the inflammatory response of the innate immune system, especially through macrophages, promotes arterial remodelling (Nazari-Jahantigh et al. 2012) .
Obviously, we cannot exclude that the difference of miR-146a levels between CHF patients and healthy individuals may be attributed to factors far beyond vascular senescence. Moreover, the present work involved a limited number of patients and only largescale multicentre studies will determine the potential use of circulating miRs (plasma and subpopulation of circulating cells) as senescence-associated biomarkers. Overall, our investigation suggests that miR-146a is a marker of a senescence-associated pro-inflammatory status in vascular remodelling cells. 
